Stoke Therapeutics, Inc. · NASDAQ:STOK
BlackRock Portfolio Management LLC reported a 5.10% stake in Stoke Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed Apr 15, 2025
BlackRock Portfolio Management LLC reported a 5.10% stake in Stoke Therapeutics, Inc., 2,743,502 shares, as a passive investor on Mar 31, 2025. Filed Apr 15, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 2,743,502
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock Portfolio Management LLC | 5.10% | 2,743,502 |
Source
Related
- Stoke Therapeutics, Inc.
- BlackRock Portfolio Management LLC
- Stoke Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jul 15, 2025
- Form 4 · Allan Jonathan · Oct 2, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026